Stereotactic Body Radiation Therapy With or Without Nivolumab in Treating Patients With Stage I-IIA or Recurrent Non-small Cell Lung Cancer
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Eli Lilly and Company
Technische Universität Dresden
Travera Inc
Turning Point Therapeutics, Inc.
M.D. Anderson Cancer Center
ViroMissile, Inc.
Harpoon Therapeutics, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)
University of Nebraska
Eli Lilly and Company
Ohio State University Comprehensive Cancer Center
M.D. Anderson Cancer Center
Massive Bio, Inc.
Chongqing Precision Biotech Co., Ltd
Phanes Therapeutics
Société Algérienne de Formation et de Recherche en Oncologie
Circle Pharma
Jonsson Comprehensive Cancer Center
Nuvation Bio Inc.
Cancer Research UK
Hoffmann-La Roche
Nanjing First Hospital, Nanjing Medical University
EpicentRx, Inc.
National Cancer Institute (NCI)
Centre Georges Francois Leclerc
National Cancer Institute (NCI)
Taproot Health
Travera Inc
University of Milano Bicocca
University of California, San Francisco
Provectus Pharmaceuticals
M.D. Anderson Cancer Center
Peking Union Medical College Hospital
H. Lee Moffitt Cancer Center and Research Institute
SpeciCare
M.D. Anderson Cancer Center
National Institutes of Health Clinical Center (CC)
Wake Forest University Health Sciences
University of Maryland, Baltimore
SWOG Cancer Research Network
Novartis
Stanford University
Yale University
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Memorial Sloan Kettering Cancer Center
Novartis
Rutgers, The State University of New Jersey
Tel-Aviv Sourasky Medical Center